for DLBCL the deadliest subtype of non-hodgkins lymphoma. I am publishing a manuscript on my method at this time and I have a collaboration with the Lymphoma group at Cornell to use their data for the next version (LYMPS v.2.0). I have been associated for the past several years with Joint Center for Syst